3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Vomiting
14
Nausea
13
Ovarian Neoplasms
4
Neoplasms
4
Lymphoma
4
Leukemia, Myeloid, Acute
4
Breast Neoplasms
4
Sezary Syndrome
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Testicular Neoplasms
2
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Neuroblastoma
2
Neoplasms, Plasma Cell
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Neutrophilic, Chronic
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Myeloid, Accelerated Phase
2
Interventions
fludarabine phosphate
18
Whole-Body Irradiation
12
Peripheral Blood Stem Cell Transplantation
12
Mycophenolic Acid
11
ruxolitinib
10
Busulfan
10
Tacrolimus
9
Cyclophosphamide
9
fludarabine
6
Methotrexate
5
Melphalan
5
Cyclosporine
5
Hydroxyurea
4
Antilymphocyte Serum
4
pomalidomide
3
givinostat hydrochloride
3
givinostat
3
Stem Cell Transplantation
3
Prednisone
3
Lenalidomide
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
thymoglobulin
2
peginterferon alfa-2a
2
merphos
2
Surveys and Questionnaires
2
Radiotherapy
2
Imatinib Mesylate
2
Etoposide
2
Dasatinib
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Polycythemia Vera
×
Aprepitant
×
Clear all
No trials found.